Cargando…
Editorial for targets and anticancer drug research
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237752/ https://www.ncbi.nlm.nih.gov/pubmed/28119803 http://dx.doi.org/10.1016/j.apsb.2016.12.004 |
| _version_ | 1782495579359674368 |
|---|---|
| author | . |
| author_facet | . |
| author_sort | . |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5237752 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52377522017-01-24 Editorial for targets and anticancer drug research . Acta Pharm Sin B Article Elsevier 2017-01 2017-01-14 /pmc/articles/PMC5237752/ /pubmed/28119803 http://dx.doi.org/10.1016/j.apsb.2016.12.004 Text en © 2017 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Article . Editorial for targets and anticancer drug research |
| title | Editorial for targets and anticancer drug research |
| title_full | Editorial for targets and anticancer drug research |
| title_fullStr | Editorial for targets and anticancer drug research |
| title_full_unstemmed | Editorial for targets and anticancer drug research |
| title_short | Editorial for targets and anticancer drug research |
| title_sort | editorial for targets and anticancer drug research |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237752/ https://www.ncbi.nlm.nih.gov/pubmed/28119803 http://dx.doi.org/10.1016/j.apsb.2016.12.004 |
| work_keys_str_mv | AT editorialfortargetsandanticancerdrugresearch |